Effect of Pancreaticoduodenectomy on the Course of Hepatic Steatosis

Hsin-Hsien Yu; Yan-Shen Shan; Pin-Wen Lin
September 2010
World Journal of Surgery;Sep2010, Vol. 34 Issue 9, p2122
Academic Journal
The progression of hepatic steatosis after pancreaticoduodenectomy (PD) is controversial. This study was designed to determine whether PD would influence the course of hepatic steatosis. Patients admitted for PD and distal pancreatectomy (DP) from January 2004 to January 2008 were enrolled. Exclusion criteria included liver metastasis, severe obesity (body mass index >30), diabetic mellitus, excessive alcohol consumption, and unavailable preoperative and 6-month postoperative unenhanced CT images. The pre-PD and post-PD liver attenuation, ratio, and difference of liver-to-spleen attenuation between liver and spleen attenuation were compared. Fifty patients who underwent PD and 20 patients who underwent DP were eligible. The mean follow-up period was 18.2 ± 1.6 months for the PD group and 19.7 ± 1.7 months for the DP group. Liver attenuation after PD was significantly decreased from 52.3 ± 1.1 H. to 47.6 ± 2 H. ( p = 0.044), but no difference was observed in spleen attenuation. The liver-to-spleen attenuation ratio after PD also was significantly decreased: 1.12 ± 0.02 versus 1.01 ± 0.04 ( p = 0.033). No difference in liver attenuation was found in the DP group. The female gender was a significant risk factor. The liver attenuation of CT images decreases in patients who receive PD, which implicates that hepatic steatosis can develop after PD; however, the mechanism needs to be elucidated.


Related Articles

  • Clinical characteristics of de novo nonalcoholic fatty liver disease following pancreaticoduodenectomy. Tanaka, Naoki; Horiuchi, Akira; Yokoyama, Takahide; Kaneko, Gengo; Horigome, Naoto; Yamaura, Takahiro; Nagaya, Tadanobu; Komatsu, Michiharu; Sano, Kenji; Miyagawa, Shin-ichi; Aoyama, Toshifumi; Tanaka, Eiji // Journal of Gastroenterology;Jun2011, Vol. 46 Issue 6, p758 

    Background: Hepatic steatosis may develop after pancreatic resection, but its clinicopathological features remain unclear. We explored the clinical characteristics of newly appearing nonalcoholic fatty liver disease (NAFLD) after pancreaticoduodenectomy (PD), designated as de novo NAFLD after...

  • Pleomorphic Carcinoma of the Pancreas: Reappraisal of Surgical Resection. Yamaguchi, K.; Nakamura, K.; Shimizu, S.; Yokohata, K.; Morisaki, T.; Chijiiwa, K.; Tanaka, M. // American Journal of Gastroenterology;Jul1998, Vol. 93 Issue 7, p1151 

    Pleomorphic carcinoma is a rare variant of pancreatic exocrine carcinoma. The aim of this communication is to reappraise surgical resection of pleomorphic carcinoma of the pancreas. Clinicopathological findings of four Japanese patients with pleomorphic carcinoma of the pancreas were reviewed...

  • Carotid lesions in outpatients with nonalcoholic fatty liver disease. Ramilli, Stefano; Pretolani, Stefano; Muscari, Antonio; Pacelli, Barbara; Arienti, Vincenzo; Keeffe, Emmet B. // World Journal of Gastroenterology;10/14/2009, Vol. 15 Issue 38, p4770 

    AIM: To ascertain whether carotid lesions are more prevalent in outpatients with incidental findings of nonalcoholic fatty liver disease (NAFLD) at abdominal ultrasound (US). METHODS: One hundred and fifty-four consecutive outpatients (age range 24-90 years, both sexes) referred by general...

  • Light and Moderate Alcohol Consumption Significantly Reduces the Prevalence of Fatty Liver in the Japanese Male Population. Gunji, Toshiaki; Matsuhashi, Nobuyuki; Sato, Hajime; Fujibayashi, Kazutoshi; Okumura, Mitsue; Sasabe, Noriko; Urabe, Akio // American Journal of Gastroenterology;Sep2009, Vol. 104 Issue 9, p2189 

    OBJECTIVES:The effect of alcohol consumption on the liver is controversial. Recent reports have suggested that moderate alcohol consumption decreases the prevalence of elevated alanine aminotransferase levels. The role of alcohol consumption in the development of fatty liver (FL), however, has...

  • Quantitative measurement of ultrasound attenuation and Hepato-Renal Index in Non-Alcoholic Fatty Liver Disease. von Volkmann, Hilde Løland; Flesland Havre, Roald; Marit Løberg, Else; Haaland, Terese; Immervoll, Heike; Haukeland, John Willy; Hausken, Trygve; Helge Gilja, Odd // Medical Ultrasonography;Mar2013, Vol. 15 Issue 1, p16 

    Objective: The aim of this study was to non-invasively explore new methods of ultrasound attenuation measurements in livers of patients with Non-Alcoholic-Fatty-Liver-Disease (NAFLD) and to measure the liver tissue elasticity. Material and method: Sixteen patients with NAFLD, twelve patients...

  • Recreational Drugs: a New Health Hazard for Patients with Concomitant Chronic Liver Diseases. Tarantino, Giovanni; Citro, Vincenzo; Finelli, Carmine // Journal of Gastrointestinal & Liver Diseases;Mar2014, Vol. 23 Issue 1, p79 

    Our purpose in this article is to review the effects of recreational drugs, used either on their own but principally combined with alcohol consumption, in determining hepatic injury or influencing the evolution of some chronic diseases of the liver, specifically HCV infection and NAFLD. A...

  • health handbook. Adams, Penny // Good Health & Medicine;Apr2007, p18 

    The article answers a question about fatty liver. Fatty liver refers to abnormal build-up of fat in liver cells and the problems causing this are excess alcohol, obesity and type 2 diabetes. It is important to treat the causes of fatty liver and avoid alcohol, as severe cases may progress to...

  • Absence of Perilipin 2 Prevents Hepatic Steatosis, Glucose Intolerance and Ceramide Accumulation in Alcohol-Fed Mice. Carr, Rotonya M.; Peralta, Giselle; Yin, Xiaoyan; Ahima, Rexford S. // PLoS ONE;May2014, Vol. 9 Issue 5, p1 

    Background: Perilipin 2 (Plin2) is a lipid droplet protein that has roles in both lipid and glucose homeostasis. An increase in Plin2 in liver is associated with the development of steatosis, glucose intolerance, and ceramide accumulation in alcoholic liver disease. We investigated the role of...

  • 73-Year-Old Man With Increasing Abdominal Girth and Dyspnea. REPPERT, SARA L.; WITTICH, CHRISTOPHER M. // Mayo Clinic Proceedings;Oct2011, Vol. 86 Issue 10, p1002 

    The article reports on nonalcoholic fatty liver disease (NAFLD), which begins with steatosis and ends with cirrhosis. It states the histologic changes in NAFLD are similar to those in alcoholic liver disease, but occurs in patients who report drinking little alcohol. It states diabetes, obesity...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics